Camelot Portfolios’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Camelot Portfolios's PFE Position: Q3 2024 in Review
Camelot Portfolios sold out of Pfizer (PFE) in Q3 2024, closing a stake of 222 shares — an estimated $6.2K sold.
Camelot Portfolios first reported a position in PFE in Q2 2013 and held it in 17 quarters. The position peaked at $1.17M in Q3 2013. 2,915 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- Camelot Portfolios reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
- Camelot Portfolios sold 222 Pfizer shares in Q3 2024, an estimated $6.2K.
- Camelot Portfolios first reported a position in Pfizer in Q2 2013 and held it in 17 quarters.
- Camelot Portfolios's Pfizer position peaked at $1.17M in Q3 2013.
- 2,915 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on Camelot Portfolios's 13F filing for Q3 2024, filed 12 Nov 2024.